JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Flyer
Biological validation solutions for AI-based drug screening
AI-based screening is reshaping drug discovery by rapidly identifying promising targets, compounds and hypotheses from vast datasets.
The critical next step? Biological validation, with lab-in-the-loop approaches, to turn AI predictions into confident pipeline decisions.
As your strategic partner, and drawing on decades of drug discovery screening expertise, Revvity provides comprehensive solutions that support high-quality biological validation, helping bridge the gap between AI predictions and biological reality at scale.
For research use only. Not for use in diagnostic procedures.
Download Resource
Biological validation solutions for AI-based drug screening
